Akebia Ther Stock Performance
| AKBA Stock | USD 1.88 0.06 3.30% |
On a scale of 0 to 100, Akebia Ther holds a performance score of 7. The firm shows a Beta (market volatility) of 1.81, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Akebia Ther will likely underperform. Please check Akebia Ther's jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to make a quick decision on whether Akebia Ther's price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Akebia Ther are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Akebia Ther sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | When Can We Expect A Profit From Akebia Therapeutics, Inc. | 09/06/2024 |
2 | Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply Contract to Enable Access to Vafseo for Patients on Dialysis | 10/07/2024 |
3 | CMS Grants TDAPA Reimbursement for Vafseo beginning January 1, 2025 | 10/10/2024 |
4 | Akebia Therapeutics Signs Commercial Supply Contract with Leading Dialysis Organization to Enable Access to Vafseo for Patients on Dialysis | 10/22/2024 |
5 | Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 11/01/2024 |
6 | Acquisition by Rogers Michael W of 30000 shares of Akebia Ther subject to Rule 16b-3 | 11/05/2024 |
7 | Akebia Q3 2024 Earnings Preview | 11/06/2024 |
8 | Akebia GAAP EPS of -0.10, revenue of 37.4M | 11/07/2024 |
9 | Akebia Therapeutics Inc Q3 2024 Earnings Call Highlights Navigating Revenue Challenges ... | 11/08/2024 |
10 | Q3 2024 Earnings Hold Akebia Therapeutics - Seeking Alpha | 11/20/2024 |
| Begin Period Cash Flow | 93.2 M |
Akebia |
Akebia Ther Relative Risk vs. Return Landscape
If you would invest 155.00 in Akebia Ther on August 24, 2024 and sell it today you would earn a total of 33.00 from holding Akebia Ther or generate 21.29% return on investment over 90 days. Akebia Ther is currently generating 0.3737% in daily expected returns and assumes 3.9047% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Akebia, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Akebia Ther Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Akebia Ther's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Akebia Ther, and traders can use it to determine the average amount a Akebia Ther's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0957
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AKBA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.9 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Akebia Ther is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Akebia Ther by adding it to a well-diversified portfolio.
Akebia Ther Fundamentals Growth
Akebia Stock prices reflect investors' perceptions of the future prospects and financial health of Akebia Ther, and Akebia Ther fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Akebia Stock performance.
| Return On Equity | -5.53 | ||||
| Return On Asset | -0.0937 | ||||
| Profit Margin | (0.27) % | ||||
| Operating Margin | (0.33) % | ||||
| Current Valuation | 411.65 M | ||||
| Shares Outstanding | 218.18 M | ||||
| Price To Earning | (4.84) X | ||||
| Price To Book | 4.12 X | ||||
| Price To Sales | 2.34 X | ||||
| Revenue | 194.62 M | ||||
| Gross Profit | 140.04 M | ||||
| EBITDA | (6.87 M) | ||||
| Net Income | (51.92 M) | ||||
| Cash And Equivalents | 143.89 M | ||||
| Cash Per Share | 0.78 X | ||||
| Total Debt | 104.18 M | ||||
| Debt To Equity | 2.15 % | ||||
| Current Ratio | 1.30 X | ||||
| Book Value Per Share | (0.24) X | ||||
| Cash Flow From Operations | (23.38 M) | ||||
| Earnings Per Share | (0.22) X | ||||
| Market Capitalization | 397.09 M | ||||
| Total Asset | 241.7 M | ||||
| Retained Earnings | (1.61 B) | ||||
| Working Capital | 18.28 M | ||||
| Current Asset | 141.02 M | ||||
| Current Liabilities | 11.87 M | ||||
About Akebia Ther Performance
By analyzing Akebia Ther's fundamental ratios, stakeholders can gain valuable insights into Akebia Ther's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Akebia Ther has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Akebia Ther has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 77.24 | 73.38 | |
| Return On Tangible Assets | (0.35) | (0.37) | |
| Return On Capital Employed | (0.33) | (0.34) | |
| Return On Assets | (0.21) | (0.23) | |
| Return On Equity | 1.70 | 1.78 |
Things to note about Akebia Ther performance evaluation
Checking the ongoing alerts about Akebia Ther for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Akebia Ther help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Akebia Ther may become a speculative penny stock | |
| Akebia Ther had very high historical volatility over the last 90 days | |
| Akebia Ther has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 194.62 M. Net Loss for the year was (51.92 M) with profit before overhead, payroll, taxes, and interest of 140.04 M. | |
| Akebia Ther currently holds about 143.89 M in cash with (23.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78. | |
| Akebia Ther has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Q3 2024 Earnings Hold Akebia Therapeutics - Seeking Alpha |
- Analyzing Akebia Ther's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Akebia Ther's stock is overvalued or undervalued compared to its peers.
- Examining Akebia Ther's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Akebia Ther's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Akebia Ther's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Akebia Ther's stock. These opinions can provide insight into Akebia Ther's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Akebia Stock analysis
When running Akebia Ther's price analysis, check to measure Akebia Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Ther is operating at the current time. Most of Akebia Ther's value examination focuses on studying past and present price action to predict the probability of Akebia Ther's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Ther's price. Additionally, you may evaluate how the addition of Akebia Ther to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |